Incannex Healthcare IXHL 深 滬
已收盤 02-06 16:00:00 美东时间
0.288
+0.038
+15.20%
華盛通- 最 高0.30
- 今 開0.2617
- 成交量 859.65万股
- 最 低 0.2558
- 昨 收 0.25
- 總市值 9971.29万
- 52周最高 1.82
- 市盈率 靜 --
- 換手率 2.48%
- 52周最低 0.08
- 委 比 67.28%
- 總股本 3.46亿
- 歷史最高 360.00
- 量 比 1.09
- 振 幅 17.68%
- 歷史最低 0.08
- 每 手 1
- 風險率 0.39%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Incannex Forms Clinical Advisory Board for Psilocybin Program
Incannex Healthcare Limited Sponsored ADR ( ($IXHL) ) has provided an announcem...
01-22 20:58
Incannex Healthcare Announces Formation of Clinical Advisory Board for PSX-001 Program
Incannex Healthcare Inc. announced the formation of a Clinical Advisory Board (CAB) to support the advancement of its PSX-001 program for generalized anxiety disorder. The CAB includes leading experts in psychiatry, neurobiology, and psychopharmacology, who will provide guidance on clinical trial design, regulatory engagement, and strategic approaches. This step aims to strengthen scientific rigor and patient-focused development, reflecting a str...
01-22 13:00
美股夜盘 | Classover Holdings, Inc. Class B涨13.61%，嘉楠科技涨5.98%
奈飞涨-5.09%；房多多涨-3.33%；Incannex Healthcare涨-1.37%
01-21 10:28
美股夜盘 | Incannex Healthcare涨8.13%，房多多涨6.49%
Incannex Healthcare涨8.13%；房多多涨6.49%；安高盟涨6.03%
01-15 16:02
美股夜盘 | Incannex Healthcare涨11.65%，房多多涨5.19%
Incannex Healthcare涨11.65%；房多多涨5.19%；Classover Holdings, Inc. Class B涨2.56%
01-15 14:02
美股夜盘 | Classover Holdings, Inc. Class B涨10.31%，PMGC Holdings Inc.涨3.93%
Classover Holdings, Inc. Class B涨10.31%；PMGC Holdings Inc.涨3.93%；房多多涨3.25%
01-15 10:02
Incannex Healthcare Intends To Advance IHL-42X, Progress PSX-001 To Next Clinical Phase In 2026
Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies, provides a 2025 corporate year-in-review and outlook for 2026, highlighting substantial
01-14 21:04
Incannex Highlights Pivotal 2025 Clinical and Financial Milestones
An announcement from Incannex Healthcare Limited Sponsored ADR ( ($IXHL) ) is n...
01-14 20:58
Incannex Healthcare Delivers Transformational 2025 Progress and Outlines Well-Funded Outlook for 2026
Incannex Healthcare enters 2026 with over $70 million in cash, two positive Phase 2 programs, FDA Fast Track Designation for its lead OSA candidate, and funding runway into 2027. Key 2025 achievements include successful Phase 2 trials for IHL-42X (OSA) and PSX-001 (GAD), financial strengthening, and strategic initiatives.
01-14 13:00
美股夜盘 | MP Materials Corp Class A涨1.88%，默沙东涨1.81%
哈莫尼黄金涨-3.36%；SEALSQ Corp.涨-1.84%；金田涨-1.11%
01-13 09:12
